首页> 美国卫生研究院文献>Molecular Therapy. Nucleic Acids >CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations
【2h】

CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations

机译:CRISPR启动损失:通过碱编辑诱导的起始密码子突变的基因沉默的新颖和实用的替代品

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

CRISPR-Cas9-mediated gene knockout and base-editing-associated induction of STOP codons (iSTOP) have been widely used to exterminate the function of a coding gene, while they have been reported to exhibit side effects. In this study, we propose a novel and practical alternative method referred to as CRISPR Start-Loss (CRISPR-SL), which eliminates gene expression by utilizing both adenine base editors (ABEs) and cytidine base editors (CBEs) to disrupt the initiation codon (ATG). CRISPR-SL has been verified to be a feasible strategy on the cellular and embryonic levels (mean editing efficiencies up to 30.67% and 73.50%, respectively) and in two rabbit models mimicking Otc deficiency (Otc gene) and long hair economic traits (Fgf5 gene).
机译:CRISPR-CAS9介导的基因敲除和碱编辑相关诱导的止压密码子(ISTOP)被广泛用于消灭编码基因的功能,同时据报道它们表现出副作用。在这项研究中,我们提出了一种新颖的和实用的替代方法,称为CRISPR起动损失(CRISPR-S1),其通过利用腺嘌呤基础编辑器(eBES)和胞苷基础编辑器(CBES)来消除基因表达来破坏发起密码子(ATG)。 CRISPR-SL已被验证是一种可行的细胞和胚胎水平的策略(平均编辑效率,分别为30.67%和73.50%)和模拟OTC缺乏(OTC基因)和长发经济特征的两只兔子模型(FGF5基因)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号